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ABSTRACT
Introduction: Visceral leishmaniasis (VL) is a neglected tropical disease with a complex 
immune response in different organs. This pattern of organ-specific immune response has never 
been evaluated in the gastrointestinal tract. The aim of this study was to determine the in situ 
immune response in duodenal biopsies on patients with VL. Methods: A case-control study 
was conducted on 13 patients with VL in comparison with nine controls. The immune response 
was evaluated using immunohistochemistry, for CD4, CD8, CD68, IL-4, IFN-γ, TNF-α and 
IL-10. Histological findings from the villi, crypts and inflammatory process were analyzed. 
Results: All the cases of VL presented Leishmania antigens. No antigen was detected in the 
control group. The villus size was greater in the VL patients (p < 0.05). CD68 (macrophages) 
and CD4 levels were higher in the VL patients (p < 0.05). No differences in the expression of 
CD8, TNF-α, IL-10 or IL-4 were demonstrated. The number of cells expressing IFN-γ was 
lower in the VL patients (p < 0.05). Conclusions: Low levels of cytokines were found in the 
gastrointestinal tract of patients with VL. This pattern was not found in other organs affected 
by the disease. Immunotolerance of this tissue against Leishmania could explain these findings, 
as occurs with intestinal bacteria. 
Key-words: Visceral leishmaniasis. Leishmaniasis. Leishmania.
RESUMO
Introdução: Leishmaniose visceral (LV) é uma doença tropical negligenciada com uma resposta 
imune complexa em diferentes órgãos. Este padrão de resposta imune órgão-específica nunca 
foi avaliada no trato gastrointestinal. O objetivo deste estudo foi determinar a resposta imune 
in situ em biópsias duodenais de pacientes com LV. Métodos: Um estudo de caso controle 
com 13 pacientes com LV foi comparado com 9 controles. A resposta imune foi avaliada por 
imunohistoquímica para CD4, CD8, CD68, IL-4, IFN-γ, TNF-α e IL-10. Achados histológicos 
nos vilos, criptas e processo inflamatório foram analisados. Resultados: Todos os casos de LV 
apresentaram antígenos de Leishmania. Nenhum antígeno foi encontrado no grupo controle. 
O tamanho do vilo foi maior em pacientes com LV (p < 0,05). CD68 (macrófagos) e CD4 
estavam aumentados em pacientes com LV (p < 0,05). Nenhuma diferença foi demonstrada 
na expressão de CD8, TNF-α, IL-10 e IL-4. O número de células expressando IFN-γ foi 
mais baixo que no grupo controle (p < 0,05). Conclusões: Baixos níveis de citocinas foram 
encontrados no trato gastrointestinal de pacientes com LV. Este padrão não foi encontrado 
em outros órgãos acometidos pela doença. Uma imunotolerância do tecido contra Leishmania 
poderia explicar estes achados, como ocorre com as bactérias entéricas. 
Palavras-chaves: Leishmaniose visceral. Leishmaniose. Leishmania.
Leishmaniasis is a neglected tropical disease 
occurring in more than 80 countries throughout 
the world with increasing numbers of cases in some 
regions. The disease usually presents in two clinical 
forms: visceral and cutaneous. The latter is recognized 
as localized hard-to-treat ulcers. The visceral form is 
a chronic disease leading to hepatosplenomegaly 
with pancytopenia1. The immune pattern of visceral 
leishmaniasis (VL) associated with cytopenia is 
responsible for recurrent bacterial infection, which 
is a common cause of death in these patients.
Opportunistic bacteria gain access through 
the respiratory, the urinary and, especially, the 
digestive tract. The mechanism through which 
bacterial translocation occurs is generally explained 
by cytopenia. Nevertheless, a recent study showed 
that local immune factors may be the causes of these 
complications, including specific T cell depletion with 
cell deactivation and further cytokine imbalance2. This 
previous study demonstrated the existence of immune 
dissociation in the lungs. However, no studies have 
evaluated local immune conditions in the digestive 
tract, which is considered to be the organ most 
associated with bacterial translocation, because of the 
area and the major bacterial load. Furthermore, one 
study has revealed that 12% of patients with VL show 
gastrointestinal symptoms3, while other studies have 
demonstrated impairment of vitamin A absorption 
among VL patients4 and colitis in dogs5. 
The aim of the present study was to determine 
the in situ immune response in the gastrointestinal 
tract of patients with VL, by means of cell/cytokine 
evaluation by means of histopathological findings.
METHODS
Cases
A case-control study was conducted among 
children with VL who were diagnosed through 
findings of amastigotes in the bone marrow, in 
association with typical clinical findings. In Brazil, 
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RESULTS
DISCUSSION
VL is caused by Leishmania infantum chagasi, and all cases 
included in this study were from the city of Natal, in northeastern 
Brazil, and were recruited between January 2003 and January 
2004. All the patients underwent endoscopy with duodenal 
biopsy by means of Watson’s capsule, before the treatment for VL. 
The control group included children who underwent endoscopy 
because of gastrointestinal symptoms but who showed normal 
examinations for VL. 
Histology
The duodenal tissue was fixed in 10% neutral-buffered formalin, 
embedded in paraffin, sectioned to micron thicknesses and stained 
with hematoxylin and eosin. Semi-quantitative methods were used 
to evaluate the size of the villi (0 = normal to 3 = atrophic), crypt 
characteristics (0 = normal to 3 = hyperplasia with hypertrophy four 
times normal values) and the presence of an inflammatory process 
(0 = normal to 3 = significant inflammatory process). The villus/
crypt ratio was also analyzed.
Immunohistochemical detection of cells, inflammation 
phenotype and cytokines
The in situ immune response was studied through cytokine 
analysis and immunohistochemical study of phenotypic markers. 
The paraffin-embedded duodenal biopsies were resected and 5μm 
sections were mounted on sylane-treated slides. The sections were 
subjected to immunohistochemical processing with monoclonal 
antibodies, using the streptavidin-biotin peroxidase method with 
an endogenous biotin blocking system (Dako, Carpinteria, CA, 
USA) with modifications as described elsewhere6. Positive and 
negative control biopsies were used to avoid bias. The following 
monoclonal antibodies for cell phenotypes and cytokines were 
used in this process: CD4 (M834/Dako, Denmark), CD8 
(M7103/Dako, Denmark), CD68 (M786/Dako, Denmark), IL-4 
(AB204/R&D Systems, Minneapolis, MN, USA), IL-10 (MAB 
217/R&D Systems), TNF-α (IP300/Genzyme, UK) and IFN-γ 
(IP500/Genzyme, UK).
The presence of Leishmania in the tissue was determined by 
means of antigen detection using immunohistochemistry as previous 
described2. We classified the results as positive or negative. No 
quantitative method was used.
Data analysis
Quantitative estimates of the different cell subsets in each 
biopsy were analyzed according to the density of the labeled 
cells for each stain (immunohistochemistry), using a grid scale, 
with 10 × 10 subdivisions in an area of 10mm2, to count fields 
under high magnification (×400) in at least 10 fields, as described 
elsewhere7.
The cytokine and immunolabeled cell medians in the control and 
VL tissues were compared by means of the nonparametric Mann-
Whitney test. We took into consideration all differences in which 
the likelihood of similarity (p < 0.05) was significant. The chi-square 
test or the Fisher exact test was used, as appropriate.
Ethical
This study was approved by the Ethics Committee of Hospital 
das Clinicas, Federal University of Rio Grande do Norte. Cases 
with immunodeficiency, comorbidities and previous treatment 
were excluded.
Thirteen patients with VL were evaluated and nine patients were 
included in the control group. The median age was 3.14 years (range: 
1-9) in the VL group and 7.6 years (range: 3-12) in the control group 
(p < 0.05). Leishmania antigens were detected in all patients with VL 
and none in the control group. No complication occurred following 
the endoscopic biopsy.
The results relating to villus size, crypts, villus/crypt ratio and 
inflammation are described in Table 1. The villus size was greater in 
the VL patients (p < 0.05).
The number of cells expressing CD68 (macrophages) and CD4 
was higher in the patients with VL (p < 0.05). No difference in 
CD8 expression was demonstrated. The number of cells expressing 
cytokines was also evaluated, but no differences in IFN-γ, TNF-α, 
IL-10 or IL-4 expression were found.
The number of cases expressing IFN-γ was significantly lower 
among the patients with VL (p = 0.023). The number of cells expressing 
IL-10 in the VL group was similar to the number in the control group, 
and this was also found in relation to TNF-α and IL-4. 
TABLE 1 - Case control study of patients with visceral leishmaniasis, 
evaluating the in situ immune response.
                                           Cases          Controls
Data/cases Mean SD Mean SD P value 
Villus size (grade) 1.08 0.28 0.56 0.53 0.009 
Crypt (grade) 0.54 0.52 0.56 0.53 0.94 
Villus:crypt (ratio) 1.15 0.38 0.67 0.50 0.015 
Inflammation (grade) 1.92 0.28 0.78 0.83 0.077 
CD68 (cell/mm2) 81.15 34.58 36.67 28.61 0.006 
CD4 (cell/mm2) 230.38 174.40 137.11 218.10 0.038 
CD8 (cell/mm2) 53.23 40.76 39.33 37.91 0.57 
IFN-γ (cell/mm2) 1.85 6.65 2.00 2.82 0.826 
IL-10 (cell/mm2) 13.62 20.30 30.22 32.14 0.143 
IL-4 (cell/mm2) 0.00 0.00 0.00 0.00 1 
TNF-α (cell/mm2) 2.42 5.90 0.24 0.44 0.3 
The presence of Leishmania in intestinal tissue has been 
recognized since the time of the first cases of this disease and Muigai 
et al described the pathological characteristics very well4. Here, we 
described some in situ aspects of the disease that had not been shown 
previously. The increased numbers of macrophages in the intestinal 
tissue was not a new discovery, nor was the lymphoid infiltration 
(CD4 and CD8 cells). The morphological findings regarding villi, 
crypts and inflammation were also compatible with previous 
studies. The villi may be atrophic or hypertrophic, but are found to 
be normal in most cases, including in animal studies8. These data 
explain why chronic diarrhea and malabsorption are uncommon in 
immunocompetent patients with visceral leishmaniasis9.
The findings of increased numbers of macrophages and CD4 cells 
without differences in cytokine expression between patients with VL 
and controls showed a different aspect of the immune response. This 
pattern was different from descriptions in other organs, such as the 
liver, spleen, kidney and lung10. The increased expression of IL-4 and 
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IL-10 with lower IFN-gamma is associated with an old concept of 
Th2 pattern of immune response. Nevertheless, localized cutaneous 
leishmaniasis caused by Leishmania (Viannia) braziliensis is the best 
concept of Th1 pattern. Despite these theories, the lack of difference 
in IL-4, IL-10 and TNF-α expression associated with lower levels of 
IFN-γ could be explained as an immunotolerant pattern, previously 
called a state of anergy11. 
The gut is considered to be an organ with an immune privilege, 
because of the confusing interplay between microorganisms, antigens 
and the intestinal epithelial barrier. The intestinal barrier can secrete 
immunoregulatory mediators that promote the generation of 
tolerogenic antigen-presenting cells, phagocytic innate immune cells 
and regulatory cells of the adaptive immune system. This complex 
interaction maintain the gut homeostasis12.
The presence of Leishmania did not change this microsystem 
and the tolerance of the immune response enabled survival of this 
parasite for long periods without any inflammatory process. A 
detailed evaluation of the innate immune response is necessary to 
confirm this theory. NK cell, CD4CD25fox3+ cell and apoptosis 
evaluation are simple analyses that could bring out new concepts 
regarding immunotolerance in visceral leishmaniasis, with differences 
in relation to other organs. 
Our study showed some limitations. The number of patients 
was too small to determine differences in some variables in relation 
to cytokine expression. The immune study was restricted to the 
duodenal mucosa. Studies in different parts of the gastrointestinal 
tract, such as the large intestine, should be performed because of 
their specific histological characteristics.
Dysregulation of the immunoregulatory network would lead to 
colitis, which has been described in dogs5. This would increase the 
percentage of intestinal signs and symptoms, thereby increasing the 
risk of translocation and further septicemia in such patients.
Cytokine responses in the intestine (in this case, the 
duodenum) were largely absent and only small changes in villus/
crypt structures could be observed, thus indicating that apart from 
infiltration of macrophages, the structure was largely normal. The 
only conclusion that can be drawn from the results presented is 
that duodenal biopsies from VL patients are not very different 
from those of controls, with the exception of cell infiltration and, 
possibly, increased villus size.
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